Projects per year
Personal profile
Education
- 2014-2020- Ph.D., Institute of Clinical Medicine, National Yang-Ming University
- 2000-2007 M.D., Faculty of Medicine, National Yang-Ming University
Experience
- 2023.08- Associate Professor, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University
- 2023.09- Deputy Director, Department of Medical Research, Taipei Medical University Hospital
- 2020.01- Director, Taiwan Hypertension Society (THS)
- 2020.08-2023.07 Assistant Professor, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University
- 2016.11 Attending Physician, Division of Cardiology, Department of Internal Medicine, Taipei Medical University Hospital
- 2014.08-2020.07 Adjunct Instructor, National Yang-Ming University
- 2014.07-2016.07 Attending Physician, Taipei Veterans General Hospital
Fingerprint
Dive into the research topics where Chien-Yi Hsu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 4 Finished
-
Study the Effects of Tumor Necrosis Factor Superfamily 14 (Tnfsf14) on Atherosclerosis Progression, Endothelial Function, and the Development of Cardiovascular Disease - from Basic to Clinical Study
8/1/21 → 7/31/22
Project: A - Government Institution › b - National Science and Technology Council
-
The protective mechanisms of low-dose carbon monoxide against oxidative stress-mediated inflammation in the pathogenesis of abdominal aortic aneurysm
5/1/21 → 4/30/22
Project: C - Project of Alliance › p - Taipei Medical University Hospital
-
The mechanisms and therapy of ambient air particulate mattermediated vascular inflammation
5/1/20 → 4/30/21
Project: C - Project of Alliance › p - Taipei Medical University Hospital
-
Economic evaluation of new blood pressure target for hypertensive patients in Taiwan according to the 2022 hypertension clinical practice guidelines of the Taiwan society of cardiology: a simulation modeling study
Liao, C. T., Toh, H. S., Yang, C. T., Hsu, C. Y., Lee, M. C., Chang, W. T., Chen, Z. C., Chang, H. Y. & Strong, C., Jan 2023, In: Hypertension Research. 46, 1, p. 187-199 13 p.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus) -
Peptide-Coated Bacteriorhodopsin-Based Photoelectric Biosensor for Detecting Rheumatoid Arthritis
Chen, H. M., Tsai, Y. H., Hsu, C. Y., Wang, Y. Y., Hsieh, C. E., Chen, J. H., Chang, Y. S. & Lin, C. Y., Oct 2023, In: Biosensors. 13, 10, 929.Research output: Contribution to journal › Article › peer-review
Open Access -
Tumor Necrosis Factor Superfamily 14 (LIGHT) Restricts Neovascularization by Decreasing Circulating Endothelial Progenitor Cells and Function
Hsu, C. Y., Huang, C. Y., Shih, C. M., Lin, Y. W., Huang, P. H., Lin, S. J., Liu, C. W., Lin, C. Y. & Lin, F. Y., Apr 2023, In: International journal of molecular sciences. 24, 8, 6997.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Carbon monoxide releasing molecule-2 attenuates angiotensin II-induced IL-6/Jak2/Stat3-associated inflammation by inhibiting NADPH oxidase- and mitochondria-derived ROS in human aortic smooth muscle cells
Hsu, C. Y., Vo, T. T. T., Lee, C. W., Chen, Y. L., Lin, W. N., Cheng, H. C., Vo, Q. C. & Lee, I. T., Apr 2022, In: Biochemical Pharmacology. 198, 114978.Research output: Contribution to journal › Article › peer-review
11 Citations (Scopus) -
Clinical impacts of sacubitril/valsartan on patients eligible for cardiac resynchronization therapy
Huang, H. T., Huang, J. L., Lin, P. L., Lee, Y. H., Hsu, C. Y., Chung, F. P., Liao, C. T., Chiou, W. R., Lin, W. Y., Liang, H. W. & Chang, H. Y., Dec 2022, In: ESC heart failure. 9, 6, p. 3825-3835 11 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus)
Datasets
-
NOX5-induced uncoupling of endothelial NO synthase is a causal mechanism and theragnostic target of an age-related hypertension endotype
Schmidt, H. H. H. W. (Creator), Elbatreek, M. H. (Creator), Sadegh, S. (Creator), Anastasi, E. (Creator), Guney, E. (Creator), Nogales, C. (Creator), Kacprowski, T. (Creator), Hassan, A. A. (Creator), Teubner, A. (Creator), Huang, P. (Creator), Hsu, C. (Creator), Schiffers, P. M. H. (Creator), Janssen, G. M. (Creator), Kleikers, P. W. M. (Creator), Wipat, A. (Creator), Baumbach, J. (Creator), De Mey, J. G. R. (Creator) & University, M. (Contributor), Dryad, 2022
DOI: 10.5061/dryad.70rxwdc00, http://datadryad.org/stash/dataset/doi:10.5061/dryad.70rxwdc00
Dataset